Zhi Chuan Wu

Star

Aconitum carmichaelii Debx.

Not yet clinically reviewed

Genus: Aconitum Species: carmichaelii Pinyin: Zhi Chuan Wu
Processed Sichuan Aconite Root制川乌

Traditionally used for

  • Pain & joints

Cautions & contraindications

  • Pregnancy
  • Heart conditions
  • Toxic — professional use only
Moderate evidence · 5 studies

☯ TCM Properties

Category: wind-damp dispelling
Temperature: hot
Taste: pungent, bitter
Meridians: heart, liver, kidney, spleen
Functions:

Dispels Wind-Dampness; Warms the Channels and Alleviates Pain; Dispels Cold and Alleviates Pain; Disperses Swelling and Dissipates Nodules

Traditional Chinese Uses

Zhi Chuan Wu (processed Sichuan aconite root, Aconitum carmichaelii) is an extremely toxic herb that must be carefully processed before use. After processing, it powerfully warms and opens the channels, dispels cold Dampness from deep within the joints and muscles, and relieves severe cold-type bi syndrome with intractable pain, numbness, and restricted movement. Its intense warming action is reserved for cases where cold obstruction is severe and unresponsive to milder herbs, and requires strict professional supervision throughout treatment.

Western Herbalism Properties

Actions:
analgesicstimulant

Click a node for details · double-click to expand it · Ctrl/⌘ + scroll or two fingers to zoom and pan.

Loading graph…

Botanical Description

Zhi Chuan Wu is the processed (detoxified) parent (mother) tuberous root of Aconitum carmichaelii, a stout perennial herb in the Ranunculaceae family native to central and eastern China. The plant produces an erect stem 60-150 cm tall bearing dark green palmately divided leaves with 3-5 deeply lobed segments and a terminal raceme of striking helmet-shaped deep blue-purple flowers in late summer and autumn. Below ground each plant has a conical to elongated dark brown tuberous parent root (Chuan Wu) that typically gives rise during the growing season to one or more attached daughter tubers, harvested separately as Fu Zi. The raw parent root contains highly cardiotoxic diester diterpenoid alkaloids (aconitine, mesaconitine, hypaconitine) and must be processed by prolonged boiling, sometimes with adjuncts, to hydrolyse these alkaloids into far less toxic monoester forms before use.

Active Constituents

Aconitine

Diester diterpenoid (C19-norditerpenoid) alkaloid

Concentration: 12.6 +/- 4.2 micrograms per gram in processed Chuanwu, against 117.5 +/- 5.0 micrograms per gram in the raw root (Sun et al. 2012) - roughly a 9-fold reduction

The principal toxin of the drug. Aconitine binds neurotoxin site 2 on the alpha-subunit of voltage-gated sodium channels and holds them open, causing persistent sodium influx, calcium overload through the sodium-calcium exchanger, and ventricular arrhythmia; an oral dose of about 0.2 mg can poison an adult and 2-4 mg is reported as lethal. Processing lowers but does not abolish it, which is why correctly processed Zhi Chuan Wu remains a Pharmacopoeia-graded toxic drug with a narrow therapeutic margin.

Mesaconitine

Diester diterpenoid alkaloid

Concentration: 23.8 +/- 4.9 micrograms per gram in processed Chuanwu, against 421.5 +/- 48.7 micrograms per gram raw (Sun et al. 2012) - roughly an 18-fold reduction

The most abundant diester alkaloid in the raw mother root and the one most efficiently destroyed by heating, hydrolysing first to the monoester benzoylmesaconine and then, with prolonged heating, to a non-esterified amine alkaloid. Shares aconitine's sodium-channel mechanism and is comparably cardiotoxic at milligram doses.

Hypaconitine

Diester diterpenoid alkaloid

Concentration: 38.1 +/- 2.9 micrograms per gram in processed Chuanwu, against 318 +/- 41.0 micrograms per gram raw (Sun et al. 2012) - roughly an 8-fold reduction

The most heat-resistant of the three diesters: Sun et al. found that aconitine and mesaconitine largely converted to their benzoyl analogues on boiling while hypaconitine changed little. It therefore dominates the residual diester load of a correctly processed drug and is the alkaloid most likely to be recovered from a patient who has been poisoned by an under-decocted preparation.

Benzoylaconine

Monoester diterpenoid alkaloid

Concentration: One of the three monoesters that the Chinese Pharmacopoeia sets as the potency marker for processed Chuanwu, with the diester total capped at 0.040 percent

Formed when the C8 acetyl group of aconitine is hydrolysed during soaking, boiling or steaming. It is one to two orders of magnitude less acutely toxic than aconitine while retaining anti-inflammatory and analgesic activity, and is the intended active principle of the processed drug rather than a mere degradation artefact.

Benzoylmesaconine

Monoester diterpenoid alkaloid

Concentration: Usually the most abundant monoester in the processed root; part of the Pharmacopoeia monoester assay

The hydrolysis product of mesaconitine and the main carrier of the drug's analgesic and anti-inflammatory activity. Zheng et al. showed that honey-boiling encapsulates it in roughly 250 nm supramolecular aggregates that raise its bioavailability while blocking its further hydrolysis to non-esterified alkaloids.

Benzoylhypaconine

Monoester diterpenoid alkaloid

Concentration: Third component of the Pharmacopoeia monoester assay for processed Chuanwu

Hydrolysis product of hypaconitine. Because its parent diester resists heat, benzoylhypaconine accumulates more slowly during processing than the other two monoesters.

Aconine

Amine (non-esterified, aminoalcohol) diterpenoid alkaloid

Concentration: Accumulates with prolonged heating; the endpoint of the two-step hydrolysis

The second hydrolysis step removes the C14 benzoyl group, giving an essentially non-toxic but also weakly active alkaloid. Over-processing therefore costs potency: honey-boiling is thought to work partly by arresting hydrolysis at the monoester stage rather than driving it all the way to aconine.

Songorine

C20-diterpenoid alkaloid

Concentration: Minor alkaloid of the root, measurable in rat plasma after oral Chuanwu extract

A non-ester diterpenoid alkaloid lacking the sodium-channel toxicity of the diesters; Ge et al. tracked it as one of ten marker compounds when studying the Chuanwu-Banxia interaction, and its plasma exposure was altered by co-administered Pinellia.

⚠ Drug Interactions

Raw Chuan Wu (unprocessed Aconitum carmichaelii mother root)

Major Evidence: Established

Substituting the raw drug for the processed one is the single most consequential dispensing error possible with this genus. Raw Chuanwu carries roughly 9-fold more aconitine, 18-fold more mesaconitine and 8-fold more hypaconitine than the processed root (Sun et al. 2012), and steaming or stir-frying has been reported to cut diester content by 40-80 times overall. Because the daily dose of the processed drug is set at the top of its own therapeutic window, dispensing raw material at the processed dose delivers a frankly toxic quantity of diester alkaloid. Chen et al. found that 13.5 percent of 52 laboratory-confirmed aconite poisonings in Hong Kong arose from inadequately processed herbs and a further 3.9 percent from outright dispensary error. A related corpus hazard is bibliographic: if a raw aconite record carries a Latin name ending Praeparata or Cocta, the raw and processed drugs become indistinguishable on the label.

Clinical note: Confirm on the label and the invoice that the material is Zhi Chuan Wu (Aconiti Radix Cocta / Radix Aconiti Praeparata) and not Chuan Wu (Aconiti Radix). Decoction time is a second, independent safety variable: boiling for only 30-60 minutes leaves residual toxicity, whereas two hours removed measurable toxicity in the reviewed data, so the drug must be decocted alone for at least 30-60 minutes and preferably longer before the rest of the formula is added. Keep to 1.5-3 g per day. Never dispense as a powder, tincture or pill made from undecocted material.

Antiarrhythmic drugs (amiodarone, flecainide, quinidine, lidocaine, sotalol)

Major Evidence: Probable

Residual aconitine, mesaconitine and hypaconitine act as sodium-channel agonists, locking the channel open and producing the very arrhythmias that class I and class III antiarrhythmics are given to suppress. Adding a channel-blocking or repolarisation-prolonging drug to a persistent depolarising stimulus gives unpredictable and potentially additive electrophysiological effects, and aconitine-induced arrhythmias are notoriously refractory to conventional antiarrhythmic therapy. European TCM safety guidance lists antiarrhythmic co-medication as a specific hazard for the aconites.

Clinical note: Do not prescribe processed aconite to a patient on antiarrhythmic therapy or with any known arrhythmia, structural heart disease or conduction defect. If aconite poisoning is suspected in such a patient, treat as a cardiology emergency rather than adjusting the herbal prescription.

Digoxin and other cardiac glycosides

Major Evidence: Probable

Both drug classes converge on intracellular calcium overload in the myocyte - digoxin by inhibiting the sodium-potassium ATPase, aconite alkaloids by driving sodium influx that reverses the sodium-calcium exchanger. The resulting triggered activity and ectopy are additive, and the toxic presentations overlap closely enough (nausea, bradyarrhythmia, ventricular ectopy) that one can mask the other. Co-medication with digitalis is an explicit contraindication in European TCM safety guidance for aconite drugs.

Clinical note: Absolute contraindication. Do not prescribe processed aconite with digoxin or digitoxin. In a patient presenting with arrhythmia on both, obtain a digoxin level and send blood and urine for aconitine alkaloid screening.

Ban Xia (Pinellia ternata)

Major Evidence: Probable

The Chuanwu-Banxia pair is one of the classical eighteen incompatibilities, and Ge et al. supplied a modern pharmacokinetic mechanism in rats: Pinellia enhanced the absorption of aconitine and benzoylaconine, accelerated the metabolism of mesaconitine, benzoylmesaconine, songorine and fuziline, and altered CYP isoenzyme activity in a five-probe cocktail assay (CYP3A4, CYP1A2, CYP2D6, CYP2C9, CYP2C19). Higher plasma aconitine from the same oral dose narrows an already narrow margin.

Clinical note: Avoid the combination. Where a classical formula appears to pair them, verify the source text and the intended processed forms before dispensing, and do not increase the aconite dose to compensate for the pairing.

CYP3A4 inhibitors (ketoconazole, itraconazole, clarithromycin, ritonavir, grapefruit juice)

Moderate Evidence: Possible

Aconitine alkaloids are predominantly metabolised by CYP3A4, and rodent work on aconite herb pairs has shown that manipulating CYP3A activity changes systemic exposure to the toxic alkaloids in the expected direction. Inhibiting that route should therefore raise and prolong exposure to whatever residual diester the processed drug contains. The interaction has not been quantified in humans, but the consequence of a small increase in exposure to a drug with a 0.2 mg toxic threshold is disproportionate.

Clinical note: Treat concurrent strong CYP3A4 inhibition as a reason to withhold aconite rather than to reduce its dose. Ask specifically about azole antifungals, macrolides and antiretrovirals before prescribing.

Honey (as a processing and decoction adjuvant)

Minor Evidence: Probable

Recorded here because it changes the drug rather than merely accompanying it. Wu et al. showed that honey lowered Cmax and AUC for all three diesters while raising them for benzoylaconine and benzoylmesaconine in rat plasma, and Zheng et al. found that honey-boiled Chuanwu forms about 250 nm supramolecular aggregates that encapsulate the monoesters, raise the LD50, and reduce hepatotoxicity and nephrotoxicity in mice. This is the pharmacological content of the classical honey-boiled wutou preparation.

Clinical note: Honey-boiling is a genuine additional safety measure, not a flavouring, but it does not replace correct pao zhi processing or adequate decoction time.

Dosage

Form Amount Frequency Duration Population Notes
decoction 1.5–3 g — — — ChP 2020. Must be pre-decocted (先煎) 30–60 min before adding other herbs. Corrected from a generic 9–15 g filler value.

Dui Yao — Herb Pairs

The classical two-herb combinations this herb appears in, each with an action neither herb has alone.

with Zhi Cao Wu 制草乌

The two processed aconites together powerfully dispel wind-cold-damp and relieve pain in stubborn painful obstruction.

Chronic wind-cold-damp obstruction with phlegm and blood stasis in the collaterals. Highly toxic; contraindicated in pregnancy; incompatible with Ban Xia, Gua Lou, Bei Mu, Bai Ji and Bai Lian.

Core pair of a classical formula — Xiao Huo Luo Dan, Tai Ping Hui Min He Ji Ju Fang

Evidence Tier

Moderate evidence · 5 studies

Recorded studies by study design, strongest design at the top. This is a study-design tier only, not a GRADE rating: it does not weigh risk of bias, consistency or precision.

Verified: design read from PubMed for a DOI that resolves to the cited paper Unverified: taken from the study's recorded description

Clinical Studies

Quantitative and Qualitative Analysis of Aconitum Alkaloids in Raw and Processed Chuanwu and Caowu by HPLC in Combination with Automated Analytical System and ESI/MS/MS

Aimin Sun; Bo Gao; Xueqing Ding; Chi-Ming Huang; Paul Pui-Hay But (2012) Journal of Analytical Methods in Chemistry in vitro

Analytical comparison of raw and commercially processed Chuanwu and Caowu. In Chuanwu, processing cut aconitine from 117.5 to 12.6 micrograms per gram, mesaconitine from 421.5 to 23.8, and hypaconitine from 318 to 38.1. Controlled boiling experiments at 15, 30, 60, 90 and 150 minutes showed aconitine and mesaconitine disappearing completely by 150 minutes, while hypaconitine changed comparatively little - the quantitative basis for treating decoction time as a safety variable in its own right.

Aconite Poisoning over 5 Years: A Case Series in Hong Kong and Lessons Towards Herbal Safety

Sammy Pak Lam Chen; Sau Wah Ng; Wing Tat Poon; Chi Kong Lai; Teresa Man Shan Ngan; Man Li Tse; Thomas Yan Keung Chan; Albert Yan Wo Chan; Tony Wing Lai Mak (2012) Drug Safety cohort

Fifty-two laboratory-confirmed aconite poisonings handled by a Hong Kong clinical toxicology laboratory between 2004 and 2009. Neurological toxicity occurred in 94.2 percent, cardiovascular in 88.5 percent and gastrointestinal in 59.6 percent. Causes were overdose (32.7 percent), hidden or inadvertently dispensed aconite (32.7 percent), use of inadequately processed herbs (13.5 percent) and dispensary error (3.9 percent). Inadequate boiling time, leaving the diester alkaloids insufficiently hydrolysed, is identified as a route to poisoning distinct from the processing of the crude drug.

Mechanistic insights into honey-boiled detoxification of ChuanWu: A study on alkaloid transformation and supramolecular aggregation

Yu Zheng; Nina Wei; Chang Lu; Weidong Li; Xiaobin Jia; Linwei Chen; Rui Chen; Zhipeng Chen (2025) Journal of Pharmaceutical Analysis animal

Honey-boiled and water-boiled preparations of the dried mother root of Aconitum carmichaelii were compared by UHPLC-MS/MS, transmission electron microscopy, LD50 testing and in vitro assays. Honey promoted conversion of diester to monoester alkaloids and then prevented the monoesters hydrolysing further to non-esterified alkaloids, forming roughly 250 nm supramolecular aggregates that encapsulated the monoesters and improved their bioavailability. Honey-boiled Chuanwu raised the LD50 and reduced hepatotoxicity and nephrotoxicity in mice while improving anti-inflammatory and analgesic effects.

Investigation of the drug–drug interaction and incompatibility mechanism between Aconitum carmichaelii Debx and Pinellia ternata (Thunb.) Breit

Minglei Ge; Huizi Ouyang; Ye Shang; Abdulmumin Muhammad Biu; Xiwei Wu; Caixia Li; Fanjiao Zuo; Yameng Zhu; Zixiang Xue; Jia Hao; Jun He (2024) Journal of Ethnopharmacology animal Verified: In vitro / animal

Rat pharmacokinetic and CYP cocktail study of the classical Chuanwu-Banxia incompatible pair. Pinellia enhanced absorption of aconitine and benzoylaconine, accelerated metabolism of mesaconitine, benzoylmesaconine, songorine and fuziline, and altered CYP isoenzyme activity assessed with dapsone, phenacetin, dextromethorphan, tolbutamide and omeprazole. The authors attribute the classical incompatibility to increased in vivo absorption of the toxic constituents.

The effect of compatibility of Aconiti Radix and honey on the pharmacokinetics of five Aconitum alkaloids in rat plasma

Jiaofeng Wu; Rong Duan; Haoran Deng; Lele Li; Yunli Zhao; Zhiguo Yu (2022) Biomedical Chromatography animal Verified: In vitro / animal

UHPLC-MS/MS comparison of Chuanwu decoction against a Chuanwu-honey concentrated solution in rats. Cmax and AUC fell for hypaconitine, mesaconitine and aconitine in the honey group while Tmax and half-life lengthened; Cmax and AUC rose for benzoylaconine and benzoylmesaconine. The pattern supports honey acting by shifting systemic exposure away from the diesters and towards the monoesters.

⚠ Safety & Contraindications

  • Pregnancy
  • Heart conditions
  • Toxic — professional use only

Contraindications

Contraindicated in pregnancy and in cardiac disease.

Safety Warnings

  • Processing lowers but does not remove the toxicity — the Pharmacopoeia still grades the processed root 有毒.
  • Decoct first for at least 30 to 60 minutes.
  • Incompatible with Ban Xia, Gua Lou, Bei Mu, Bai Lian and Bai Ji.

⚠ Rule-Based Cautions

These entries come from the deterministic rule tables that gate Verscienta's formula tools — classical pair prohibitions, pregnancy and lactation contraindications, and dose ceilings.

Incompatibilities (十八反 / 十九畏)

  • 十八反: Wu Tou × Ban Xia — avoid combining with Ban Xia / Pinellia (pair accepted when both members are processed)
  • 十八反: Wu Tou × Gua Lou — avoid combining with Gua Lou / Trichosanthes / Tian Hua Fen
  • 十八反: Wu Tou × Bei Mu — avoid combining with Bei Mu / Fritillaria / Chuan Bei / Zhe Bei
  • 十八反: Wu Tou × Bai Lian — avoid combining with Bai Lian / Ampelopsis
  • 十八反: Wu Tou × Bai Ji — avoid combining with Bai Ji / Bletilla

Pregnancy

Avoid toxic aconite

Breastfeeding

Avoid toxic to infant

Dose Ceiling

≤15g — prepared aconite 3–15g and must be pre-decocted; higher risks toxicity

≤6g — raw/less-processed aconite extremely toxic; keep low and pre-decoct

⚠ Toxicity Information

Level: toxic
Toxic compounds: Residual monoester alkaloids (benzoylaconine, benzoylmesaconine) after processing; incomplete processing leaves diester aconitine.
Symptoms:

As for the raw root but requiring larger doses: oral and limb numbness, nausea, palpitations and arrhythmia. Most reported poisonings follow inadequate processing or insufficient decoction.

Historical Texts

Shen Nong Ben Cao Jing (Divine Husbandman's Classic of Materia Medica)

Han dynasty, compiled c. 200 CE
Wu Tou, the aconite mother root, is entered among the inferior-class drugs, the category reserved for potent and toxic agents used briefly to attack disease rather than for long-term tonification. The entry is the origin of the two-thousand-year Chinese record of this species as a poison used medicinally.

Jin Gui Yao Lue (Essentials from the Golden Cabinet), Zhang Zhongjing

Eastern Han dynasty, c. 220 CE
Records aconite decocted in honey rather than water for the wutou preparations used in cold painful obstruction. Modern pharmacokinetic and LD50 work on honey-boiled Chuanwu shows this step measurably shifts systemic exposure from diester to monoester alkaloids.

Lei Gong Pao Zhi Lun (Master Lei's Treatise on Drug Processing), attributed to Lei Xiao

Southern and Northern Dynasties, c. 5th century CE
The earliest Chinese treatise devoted to pao zhi processing, and the textual ancestor of the prolonged soaking and boiling that distinguishes Zhi Chuan Wu from the raw drug. The tradition it records is what the modern Pharmacopoeia limit on diester alkaloid content codifies.

Ben Cao Gang Mu (Compendium of Materia Medica), Li Shizhen

Ming dynasty, 1596
Separates the Sichuan aconite (Chuan Wu, Aconitum carmichaelii) from the wild aconite (Cao Wu) and from the lateral root Fu Zi, and restates the requirement that the roots be processed before internal use.

References

  1. Ru Ya Tan; Pin Jun Ooi; Xiangyang Xu; Xu Wei; Xu Wen; Qiyue Qiu; Mun Fei Yam. Aconitum carmichaelii: a clinical-regulatory synthesis of traditional use, toxicological evidence, and global safety governance . Frontiers in Pharmacology (2026) [DOI]
  2. Xin-Yu Li; Li Zhou; Zhen-Hong Jiang; Yong Liang; Ya-Guo Fan; Zhao-Hui Ding; Hao Chen; Wen-Jun Liu; Xiang Zhou; Huan-Hua Xu. Integrated toxicology of Aconitum carmichaelii Debx.: bridging traditional toxicity-efficacy understanding and modern toxicology . Frontiers in Pharmacology (2025) [DOI]
  3. Yabin Gao; Hang Fan; Anzheng Nie; Kang Yang; Haiyan Xing; Zhiqing Gao; Liujie Yang; Zheng Wang; Linqi Zhang. Aconitine: A review of its pharmacokinetics, pharmacology, toxicology and detoxification . Journal of Ethnopharmacology (2022) [DOI]
  4. Weiye Zhang; Zhubin Zhang; Ziwen Bian; Qi Zuo; Xue Quan; Jiahao Gong; Bingling Ju; Liang Feng; Xiaobin Jia; Bing Yang. Processing-induced detoxification of toxic Traditional Chinese Medicines: a systematic review of attenuation mechanisms at physical, chemical, and in vivo levels . Chinese Medicine (2026) [DOI]
  5. Nicoleta Anca Şuţan; Alina Paunescu; Carmen Topala; Codruţa Dobrescu; Maria Cristina Ponepal; Diana Ionela Popescu (Stegarus); Liliana Cristina Soare; Radu Tamaian. Aconitine in Synergistic, Additive and Antagonistic Approaches . Toxins (2024) [DOI]

This information is for educational purposes only and is not intended to replace professional medical advice. Always consult a qualified healthcare provider before using any herbal remedy, especially if you are pregnant, nursing, or taking medications.

📝 Notes

Public notes from the community and your own private notes on Zhi Chuan Wu.

No notes yet.

Log in or register to add your own notes.

Back to Herb Database